Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Ageing Res Rev. 2023 Mar 31;87:101923. doi: 10.1016/j.arr.2023.101923

Fig. 3.

Fig. 3.

Subgroup analyses of vitamin D3 supplementation and cancer mortality by duration of intervention, health status, region, dose and regimen in all trials. Note: The FIND study appears twice in the subgroup analysis towards dose. The treatment arm with 1600 IU counted towards moderate dose and the one with 3200 IU counted towards high dose.